Effect of Ebola Progression in Liberia
By Gary S. Collins, P. Mohapatra, Baijayantimala Mishra, Johannes B Reitsma, Douglas G. Altman, Karel G. M. Moons. 2015
2,877 citations recorded by the source corpus.
Background— Prediction models are developed to aid health care providers in estimating the probability or risk that a specific disease or condition is present (diagnostic models) or that a specific event will occur in the future (prognostic models), to inform their decision making. However, the overwhelming evidence shows that the quality of reporting of prediction model studies is poor. Only with full and clear reporting of information on all aspects of a prediction model can risk of bias and potential usefulness of prediction models be adequately assessed. Methods— The Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) Initiative developed a set of recommendations for the reporting of studies developing, validating, or updating a prediction model, whether for diagnostic or prognostic purposes. This article describes how the TRIPOD Statement was developed. An extensive list of items based on a review of the literature was created, which was reduced after a Web-based survey and revised during a 3-day meeting in June 2011 with methodologists, health care professionals, and journal editors. The list was refined during several meetings of the steering group and in e-mail discussions with the wider group of TRIPOD contributors. Results— The resulting TRIPOD Statement is a checklist of 22 items, deemed essential for transparent reporting of a prediction model study. The TRIPOD Statement aims to improve the transparency of the reporting of a prediction model study regardless of the study methods used. The TRIPOD Statement is best used in conjunction with the TRIPOD explanation and elaboration document. Conclusions— To aid the editorial process and readers of prediction model studies, it is recommended that authors include a completed checklist in their submission (also available at www.tripod-statement.org).
Subfields: Epidemiology, Family Practice, Health Informatics, Medical & Health AI
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- Gary S. Collins
- Karel G. M. Moons
- Douglas G. Altman
- T. Debray
- R. Riley
- Kym I. E. Snell
- J. Ensor
- Lotty Hooft
In Family Practice
In Health Informatics
In Medical & Health AI
Citations in the corpus
- Moving beyond regression techniques in cardiovascular risk prediction: applying machine learning to address analytic challenges (2016, methodology): “This is a key component of the TRIPOD statement for reporting prognostic models.(36,37) In the traditional regression model framework, internal validation is not necessary because one (ideally) posits an analytic model before fitting it to the data.”
- Risk of bias in studies on prediction models developed using supervised machine learning techniques: systematic review (2021, background): “36 37 Although TRIPOD was not explicitly doi: 10.1136/bmj.n2281 | BMJ 2021;375:n2281 | the bmj developed for machine learning prediction models, all items are applicable.”
- Review and evaluation of penalised regression methods for risk prediction in low‐dimensional data with few events (2015, background): “Also, the results obtained from some of these non-regression-based approaches, for example, neural networks and support vector machines, may not be as intuitive and interpretable, posing concerns regarding reproducibility and transparency of the results [48].”
- External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges (2016, methodology): “The recent TRIPOD guideline 34 35 also indicates that a model’s predictive performance should be evaluated in relation to key variables, such as age or sex subgroups, rather than just across all individuals combined, which can mask any deficiencies in the model.”
- Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review (2017, methodology): “To determine how to evaluate papers, we consulted the recently published TRIPOD 14,15 guidelines for reporting of risk prediction studies and the review by D’Agostino et al. 16 and then focused on the study aspects that were particular or unique to EHR-based studies.”
- Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures (2017, background): “Finally, the understandability of classification models varies significantly and should be considered,(72) together with qualitative reporting.(92)”
- Developing clinical prediction models: a step-by-step guide (2024, positive): “10-14 PROBAST (prediction model risk-of-bias assessment tool) provides a structured way to assess the risk of bias in a prediction modelling study.”
- Radiomics: the bridge between medical imaging and personalized medicine (2017, neutral): “An excellent example is the Transparent Reporting of a multi-variable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) initiative 32 .”
- The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. (2016, neutral): “Second, recommendations or guidelines regarding parts of the radiomics analysis are already covered comprehensively elsewhere, for example, by the Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis statement on diagnostic and prognostic modeling (31).”
- PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies (2019, neutral): “A multivariable prediction model is defined as any combination or equation of two or more predictors for estimating the probability or risk for an individual.(7, 8, 33-35)”
- "The human body is a black box": supporting clinical decision-making with deep learning (2019, methodology): “, ProXXXXXXXX). The deep learning model was published and reported according to the Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) guidelines [43]. Clinical impact is being evaluated according to a preregistered clinical trial (ClinicalTrials”